155 related articles for article (PubMed ID: 22717417)
1. Identifying potential predictors of high-quality oral anticoagulation assessed by time in therapeutic international normalized ratio range: a prospective, long-term, single-center, observational study.
Costa GL; Lamego RM; Colosimo EA; Valacio RA; Moreira Mda C
Clin Ther; 2012 Jul; 34(7):1511-20. PubMed ID: 22717417
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
[TBL] [Abstract][Full Text] [Related]
3. Determinants of oral anticoagulation control in new warfarin patients: analysis using data from Clinical Practice Research Datalink.
Macedo AF; Bell J; McCarron C; Conroy R; Richardson J; Scowcroft A; Sunderland T; Rotheram N
Thromb Res; 2015 Aug; 136(2):250-60. PubMed ID: 26073321
[TBL] [Abstract][Full Text] [Related]
4. Impact of co-morbidities and patient characteristics on international normalized ratio control over time in patients with nonvalvular atrial fibrillation.
Nelson WW; Choi JC; Vanderpoel J; Damaraju CV; Wildgoose P; Fields LE; Schein JR
Am J Cardiol; 2013 Aug; 112(4):509-12. PubMed ID: 23800552
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the Quality of Chronic Anticoagulation Control With Time in Therapeutic Range in Atrial Fibrillation Patients Treated With Vitamin K Antagonists by Hemostasis Specialists: The TERRA Registry: Tiempo en rango en la República Argentina.
Tajer C; Ceresetto J; Bottaro FJ; Martí A; Casey M;
Clin Appl Thromb Hemost; 2017 Jul; 23(5):445-453. PubMed ID: 26739542
[TBL] [Abstract][Full Text] [Related]
6. A simple method to identify patients on long-term warfarin who may derive the most benefit from new oral anticoagulants.
Carrier M; Kimpton M; Wells PS; Langlois N; Kherani S; Le Gal G
Blood Coagul Fibrinolysis; 2014 Dec; 25(8):812-5. PubMed ID: 24914740
[TBL] [Abstract][Full Text] [Related]
7. Dietary vitamin K intake and stability of anticoagulation with coumarins: evidence derived from a clinical trial.
Zuchinali P; Souza GC; de Assis MC; Rabelo ER; Rohde LE
Nutr Hosp; 2012; 27(6):1987-92. PubMed ID: 23588449
[TBL] [Abstract][Full Text] [Related]
8. Differences in the quality of oral anticoagulation therapy with vitamin K antagonists in German GP practices - results of the cluster-randomized PICANT trial (Primary Care Management for Optimized Antithrombotic Treatment).
Mertens C; Siebenhofer A; Berghold A; Pregartner G; Ulrich LR; Mergenthal K; Kemperdick B; Schulz-Rothe S; Rauck S; Harder S; Gerlach FM; Petersen JJ
BMC Health Serv Res; 2019 Aug; 19(1):539. PubMed ID: 31370840
[TBL] [Abstract][Full Text] [Related]
9. Predictors of anticoagulation quality in 15 834 patients performing patient self-management of oral anticoagulation with vitamin K antagonists in real-life practice: a survey of the International Self-Monitoring Association of Orally Anticoagulated Patients.
Schaefer C; Wuillemin WA; Kessels A; Jacobson A; Nagler M
Br J Haematol; 2016 Nov; 175(4):677-685. PubMed ID: 27468696
[TBL] [Abstract][Full Text] [Related]
10. Good quality of oral anticoagulation treatment in general practice using international normalised ratio point of care testing.
Løkkegaard T; Pedersen TH; Lind B; Siersma V; Waldorff FB
Dan Med J; 2015 Feb; 62(2):. PubMed ID: 25634508
[TBL] [Abstract][Full Text] [Related]
11. Quality of oral anticoagulation with vitamin K antagonists in 'real-world' patients with atrial fibrillation: a report from the prospective multicentre FANTASIIA registry.
Esteve-Pastor MA; Rivera-Caravaca JM; Roldán-Rabadán I; Roldán V; Muñiz J; Raña-Míguez P; Ruiz-Ortiz M; Cequier Á; Bertomeu-Martínez V; Badimón L; Anguita M; Lip GYH; Marín F;
Europace; 2018 Sep; 20(9):1435-1441. PubMed ID: 29095971
[TBL] [Abstract][Full Text] [Related]
12. Quality of oral anticoagulation with phenprocoumon in regular medical care and its potential for improvement in a telemedicine-based coagulation service--results from the prospective, multi-center, observational cohort study thrombEVAL.
Prochaska JH; Göbel S; Keller K; Coldewey M; Ullmann A; Lamparter H; Jünger C; Al-Bayati Z; Baer C; Walter U; Bickel C; ten Cate H; Münzel T; Wild PS
BMC Med; 2015 Jan; 13():14. PubMed ID: 25616558
[TBL] [Abstract][Full Text] [Related]
13. INR goal attainment and oral anticoagulation knowledge of patients enrolled in an anticoagulation clinic in a Veterans Affairs medical center.
Baker JW; Pierce KL; Ryals CA
J Manag Care Pharm; 2011 Mar; 17(2):133-42. PubMed ID: 21348546
[TBL] [Abstract][Full Text] [Related]
14. Quality of vitamin K antagonist oral anticoagulation in 322 patients with atrial fibrillation - real-life data from a survey in Eastern Switzerland.
Maeder MT; König T; Bogdanovic S; Schneider I; Eugster W; Ammann P; König M; Beer J; Rickli H
Swiss Med Wkly; 2017; 147():w14503. PubMed ID: 29039622
[TBL] [Abstract][Full Text] [Related]
15. Questionable reversal of anticoagulation in the therapeutic management of cerebral haemorrhage associated with vitamin K antagonists.
Alonso de Leciñana M; Huertas N; Egido JA; Muriel A; García A; Ruiz-Ares G; Díez-Tejedor E; Fuentes B
Thromb Haemost; 2013 Dec; 110(6):1145-51. PubMed ID: 24030842
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of time in therapeutic range in anticoagulated patients: a single-center, retrospective, observational study.
Caldeira D; Cruz I; Morgado G; Stuart B; Gomes C; Martins C; João I; Pereira H
BMC Res Notes; 2014 Dec; 7():891. PubMed ID: 25491419
[TBL] [Abstract][Full Text] [Related]
17. Defining time in therapeutic range for busy clinicians: frequency of dose changes is a good surrogate marker to identify patients with suboptimal anticoagulation with warfarin.
Vijenthira A; Le Gal G; Castellucci LA; Carrier M
Thromb Res; 2014 Sep; 134(3):584-6. PubMed ID: 25037497
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulation control with daily low-dose vitamin k to reduce clinically adverse outcomes and international normalized ratio variability: a systematic review and meta-analysis.
Lam J; Schulman S; Witt DM; Vandvik PO; Qayyum F; Holbrook AM
Pharmacotherapy; 2013 Nov; 33(11):1184-90. PubMed ID: 23744743
[TBL] [Abstract][Full Text] [Related]
19. Effect of 200μG/day of vitamin K1 on the variability of anticoagulation control in patients on warfarin: a randomized controlled trial.
Majeed H; Rodger M; Forgie M; Carrier M; Taljaard M; Scarvelis D; Gonsalves C; Rodriguez RA; Wells PS
Thromb Res; 2013 Sep; 132(3):329-35. PubMed ID: 23953594
[TBL] [Abstract][Full Text] [Related]
20. Factors Affecting the Quality of Anticoagulation With Vitamin K Antagonists in Venous Thromboembolism Patients.
Rivera-Caravaca JM; Viedma-Viedma I; Roldán V
Biol Res Nurs; 2017 Mar; 19(2):198-205. PubMed ID: 27680769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
